Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W A Carter

Showing results (11-20 of 122) with videos related to

Pageof 13
Sort By:
Medical Hypotheses|January 1, 1992
An hypothesis concerning optimal therapy in HIV diseaseD Gillespie, W A Carter
Texas Reports on Biology and Medicine|January 1, 1981
Species specificity of interferonD Gillespie, W A Carter
Medicine|May 1, 1972
Viral chemotherapy: its promise and problemsE C Borden, W A Carter
Journal of the Reticuloendothelial Society|April 1, 1978
Human interferons: characterization of the major molecular componentsJ A O'Malley, W A Carter
Virology|January 15, 1981
Effect of tunicamycin on the physical properties and antiviral activities of murine L cell interferonE A Havell, W A Carter
Methods in Enzymology|January 1, 1981
Induction and production of interferon with porcine, bovine, and equine leukocytesW A Carter, F H Johnson
Nature: New Biology|November 24, 1971
Antiviral activity produced by the polycytidylic acid-hexainosinate systemP M Pitha, W A Carter
Science (New York, N.Y.)|December 27, 1974
Viral infection and host defenseW A Carter, E De Clercq
Antimicrobial Agents and Chemotherapy|February 1, 1974
Responses of the murine myeloid colony-forming cell to ansamycin antibioticsJ S Horoszewicz, W A Carter
Cancer Treatment Reports|November 1, 1978
Human interferon and its inducers: clinical program overview at Roswell Park Memorial InstituteW A Carter, J S Horoszewicz
Pageof 13

Showing results (11-20 of 122) with videos related to

Sort By:
Pageof 13
Medical Hypotheses|January 1, 1992
An hypothesis concerning optimal therapy in HIV diseaseD Gillespie, W A Carter
Texas Reports on Biology and Medicine|January 1, 1981
Species specificity of interferonD Gillespie, W A Carter
Medicine|May 1, 1972
Viral chemotherapy: its promise and problemsE C Borden, W A Carter
Journal of the Reticuloendothelial Society|April 1, 1978
Human interferons: characterization of the major molecular componentsJ A O'Malley, W A Carter
Virology|January 15, 1981
Effect of tunicamycin on the physical properties and antiviral activities of murine L cell interferonE A Havell, W A Carter
Methods in Enzymology|January 1, 1981
Induction and production of interferon with porcine, bovine, and equine leukocytesW A Carter, F H Johnson
Nature: New Biology|November 24, 1971
Antiviral activity produced by the polycytidylic acid-hexainosinate systemP M Pitha, W A Carter
Science (New York, N.Y.)|December 27, 1974
Viral infection and host defenseW A Carter, E De Clercq
Antimicrobial Agents and Chemotherapy|February 1, 1974
Responses of the murine myeloid colony-forming cell to ansamycin antibioticsJ S Horoszewicz, W A Carter
Cancer Treatment Reports|November 1, 1978
Human interferon and its inducers: clinical program overview at Roswell Park Memorial InstituteW A Carter, J S Horoszewicz
Pageof 13